155 related articles for article (PubMed ID: 2503936)
1. Serological and immunological characteristics of maternal anti-Rh(D) antibodies in predicting the severity of haemolytic disease of the newborn.
Zupańska B; Brojer E; Richards Y; Lenkiewicz B; Seyfried H; Howell P
Vox Sang; 1989; 56(4):247-53. PubMed ID: 2503936
[TBL] [Abstract][Full Text] [Related]
2. Prediction of the severity of haemolytic disease of the newborn. Quantitative IgG anti-D subclass determinations explain the correlation with functional assay results.
Garner SF; Gorick BD; Lai WY; Brown D; Taverner J; Hughes-Jones NC; Contreras M; Lubenko A
Vox Sang; 1995; 68(3):169-76. PubMed ID: 7625074
[TBL] [Abstract][Full Text] [Related]
3. Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn.
Hadley AG; Kumpel BM; Leader KA; Poole GD; Fraser ID
Br J Haematol; 1991 Feb; 77(2):221-8. PubMed ID: 2004024
[TBL] [Abstract][Full Text] [Related]
4. A comparison of in vitro tests for predicting the severity of haemolytic disease of the fetus and newborn.
Hadley AG
Vox Sang; 1998; 74 Suppl 2():375-83. PubMed ID: 9704470
[TBL] [Abstract][Full Text] [Related]
5. Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn.
Hadley AG
Transpl Immunol; 2002 Aug; 10(2-3):191-8. PubMed ID: 12216949
[TBL] [Abstract][Full Text] [Related]
6. Assessment of severity of haemolytic disease of newborn by monocyte monolayer assay.
Dhingra-Kumar N; Duguid JK; Bromilow IM
Indian J Med Res; 1995 Aug; 102():71-6. PubMed ID: 8834817
[TBL] [Abstract][Full Text] [Related]
7. Correlation of monocyte-monolayer assay results, number of erythrocyte-bound IgG molecules, and IgG subclass composition in the study of red cell alloantibodies other than D.
Zupańska B; Brojer E; McIntosh J; Seyfried H; Howell P
Vox Sang; 1990; 58(4):276-80. PubMed ID: 2399692
[TBL] [Abstract][Full Text] [Related]
8. Three examples of Rh haemolytic disease of the newborn with a negative direct antiglobulin test.
Heddle NM; Wentworth P; Anderson DR; Emmerson D; Kelton JG; Blajchman MA
Transfus Med; 1995 Jun; 5(2):113-6. PubMed ID: 7655573
[TBL] [Abstract][Full Text] [Related]
9. Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR).
Dooren MC; Kuijpers RW; Joekes EC; Huiskes E; Goldschmeding R; Overbeeke MA; von dem Borne AE; Engelfriet CP; Ouwehand WH
Lancet; 1992 May; 339(8801):1067-70. PubMed ID: 1349101
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the protective effect of maternal FcR-blocking IgG alloantibodies HLA-DR in Rh D-haemolytic disease of the newborn.
Dooren MC; van Kamp IL; Kanhai HH; Gravenhorst JB; von dem Borne AE; Engelfriet CP
Vox Sang; 1993; 65(1):55-8. PubMed ID: 8362515
[TBL] [Abstract][Full Text] [Related]
11. Mononuclear phagocyte assays, autoanalyzer quantitation and IgG subclasses of maternal anti-RhD in the prediction of the severity of haemolytic disease in the fetus before 32 weeks gestation.
Garner SF; Wiener E; Contreras M; Nicolini U; Kochenour N; Letsky E; Rodeck CH
Br J Haematol; 1992 Jan; 80(1):97-101. PubMed ID: 1536816
[TBL] [Abstract][Full Text] [Related]
12. Anti-Rh(D) IgG subclasses and severity of Rh hemolytic disease of the newborn.
Pollock JM; Bowman JM
Vox Sang; 1990; 59(3):176-9. PubMed ID: 2124753
[TBL] [Abstract][Full Text] [Related]
13. What is the best predictor of the severity of ABO-haemolytic disease of the newborn?
Brouwers HA; Overbeeke MA; van Ertbruggen I; Schaasberg W; Alsbach GP; van der Heiden C; van Leeuwen EF; Stoop JW; Engelfriet CP
Lancet; 1988 Sep; 2(8612):641-4. PubMed ID: 2901516
[TBL] [Abstract][Full Text] [Related]
14. The evaluation of maternal anti-D concentrations during pregnancy.
Filbey D; Berseus O; Sandström B; Wesström G
Early Hum Dev; 1987 Jan; 15(1):1-9. PubMed ID: 3102209
[TBL] [Abstract][Full Text] [Related]
15. First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers.
Thakral B; Agrawal SK; Dhawan HK; Saluja K; Dutta S; Marwaha N
Hematology; 2007 Oct; 12(5):377-80. PubMed ID: 17852437
[TBL] [Abstract][Full Text] [Related]
16. IgG1 and IgG3 anti-D in maternal serum and on the RBCs of infants suffering from HDN: relationship with the severity of the disease.
Lambin P; Debbia M; Puillandre P; Brossard Y
Transfusion; 2002 Dec; 42(12):1537-46. PubMed ID: 12473131
[TBL] [Abstract][Full Text] [Related]
17. The role of Rh antibodies in haemolytic disease of the newborn.
Hadley AG; Kumpel BM
Baillieres Clin Haematol; 1993 Jun; 6(2):423-44. PubMed ID: 8043933
[TBL] [Abstract][Full Text] [Related]
18. [Serological conflict: relation between antibody titer, Liley's zone and the condition of the fetus and newborn infant].
Czeszyńska M; Zieliński M; Czajkowski Z; Hnatyszyn G
Acta Haematol Pol; 1991; 22(2):279-89. PubMed ID: 1841500
[TBL] [Abstract][Full Text] [Related]
19. Transplacental IgG subclass concentrations in pregnancies at risk of haemolytic disease of the newborn.
Lubenko A; Contreras M; Rodeck CH; Nicolini U; Savage J; Chana H
Vox Sang; 1994; 67(3):291-8. PubMed ID: 7863629
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte subpopulations in healthy newborns and in immunohemolytic anemia due to Rh incompatibility.
Maślanka K; Zupańska B; Lozińska D; Brojer E
Arch Immunol Ther Exp (Warsz); 1981; 29(1):21-8. PubMed ID: 6793019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
